drugset / Trial / NCT06717360
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R in Patients with Primary Hypercholesterolemia
Timeline
- Start
- 2024-09-30
- Primary completion
- 2025-07-10
- Completion
- 2026-05-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | AG2304R | Unknown | — | Oral |
| Subject | AG2304T | Unknown | — | Oral |